{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T06:08:28Z","timestamp":1777874908831,"version":"3.51.4"},"reference-count":26,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100013739","name":"Pfizer Canada ULC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013739","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.cjca.2025.08.357","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T16:16:11Z","timestamp":1757348171000},"page":"2584-2591","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and Initial Results from the Canadian Cardiac Amyloidosis Pyrophosphate Imaging Registry (CAPER)"],"prefix":"10.1016","volume":"41","author":[{"given":"Cigdem","family":"Akincioglu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasha","family":"Aleksova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nowell","family":"Fine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Juneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terrence D.","family":"Ruddy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Small","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthieu","family":"Pelletier-Galarneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn","family":"Wells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4676-2433","authenticated-orcid":false,"given":"Robert J.H.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2025.08.357_bib1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s40119-019-0142-5","article-title":"Estimating the prevalence of transthyretin amyloid cardiomyopathy in a large in-hospital database in japan","volume":"8","author":"Winburn","year":"2019","journal-title":"Cardiol Ther"},{"key":"10.1016\/j.cjca.2025.08.357_bib2","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin amyloid cardiomyopathy: JACC Stae-of-the-Art Review","volume":"73","author":"Ruberg","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.08.357_bib3","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1093\/eurheartj\/ehv328","article-title":"Unveiling wild-type transthyretin cardiac amyloidosis as a significant and potentially modifiable cause of heart failure with preserved ejection fraction","volume":"36","author":"Castano","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2025.08.357_bib4","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.jmir.2024.02.009","article-title":"Bone scintigraphy for cardiac amyloidosis: a Canadian perspective","volume":"55","author":"Miller","year":"2024","journal-title":"J Med Imaging Radiat Sci"},{"key":"10.1016\/j.cjca.2025.08.357_bib5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.cardfail.2021.08.016","article-title":"The incidence and prevalence of cardiac amyloidosis in a large community-based cohort in alberta, canada","volume":"28","author":"Sepehrvand","year":"2022","journal-title":"J Cardiac Fail"},{"key":"10.1016\/j.cjca.2025.08.357_bib6","first-page":"322","article-title":"Canadian Cardiovascular Society\/Canadian Heart Failure Society joint position statement on the evaluation and management of patients with cardiac amyloidosis","volume":"36","author":"Fine","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2025.08.357_bib7","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cardfail.2019.08.001","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis","volume":"25","author":"Dorbala","year":"2019","journal-title":"J Card Fail"},{"key":"10.1016\/j.cjca.2025.08.357_bib8","first-page":"669","article-title":"Improvement of diagnostic accuracy of transthyretin cardiac amyloidosis (TTR-CA) with 99m technetium pyrophosphate SPECT imaging","volume":"60","author":"Flaherty","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cjca.2025.08.357_bib9","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1007\/s12350-020-02139-8","article-title":"Technetium pyrophosphate nuclear scintigraphy for cardiac amyloidosis: imaging at 1 vs 3 hours and planar vs SPECT\/CT","volume":"27","author":"Sperry","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.cjca.2025.08.357_bib10","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1007\/s12350-021-02563-4","article-title":"Diagnostic and prognostic value of technetium-99m pyrophosphate uptake quantitation for transthyretin cardiac amyloidosis","volume":"28","author":"Miller","year":"2021","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.cjca.2025.08.357_bib11","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1007\/s12350-021-02806-4","article-title":"Quantitative technetium pyrophosphate and cardiovascular magnetic resonance in patients with suspected cardiac amyloidosis","volume":"29","author":"Roshankar","year":"2022","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.cjca.2025.08.357_bib12","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.2967\/jnumed.124.267542","article-title":"Deep learning-enabled quantification of (99m)tc-pyrophosphate SPECT\/CT for cardiac amyloidosis","volume":"65","author":"Miller","year":"2024","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cjca.2025.08.357_bib13","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.jcmg.2020.02.025","article-title":"Improved quantification of cardiac amyloid burden in systemic light chain amyloidosis: redefining early disease?","volume":"13","author":"Cuddy","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2025.08.357_bib14","doi-asserted-by":"crossref","first-page":"716","DOI":"10.2967\/jnumed.120.247312","article-title":"Absolute quantitation of cardiac 99mtc-pyrophosphate using cadmium-zinc-telluride\u2013based spect\/ct","volume":"62","author":"Dorbala","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cjca.2025.08.357_bib15","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1007\/s12350-018-1326-4","article-title":"Rationale and design of the registry of fast myocardial perfusion imaging with next generation SPECT (refine SPECT)","volume":"27","author":"Slomka","year":"2020","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.cjca.2025.08.357_bib16","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.2967\/jnumed.124.268292","article-title":"The updated registry of fast myocardial perfusion imaging with next-generation SPECT","volume":"65","author":"Miller","year":"2024","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cjca.2025.08.357_bib17","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jcmg.2024.01.006","article-title":"AI-defined cardiac anatomy improves risk stratification of hybrid perfusion imaging","volume":"17","author":"Miller","year":"2024","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.cjca.2025.08.357_bib18","doi-asserted-by":"crossref","first-page":"652","DOI":"10.2967\/jnumed.122.264423","article-title":"Deep learning coronary artery calcium scores from SPECT\/CT attenuation maps improve prediction of major adverse cardiac events","volume":"64","author":"Miller","year":"2023","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cjca.2025.08.357_bib19","article-title":"Validation of a quantitative ratio-based method for myocardial PYP uptake in cardiac amyloidosis","volume":"66","author":"Celiker Guler","year":"2025","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cjca.2025.08.357_bib20","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1001\/jamacardio.2022.1781","article-title":"A simple score to identify increased risk of transthyretin amyloid cardiomyopathy in heart failure with preserved ejection fraction","volume":"7","author":"Davies","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.cjca.2025.08.357_bib21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jacc.2020.11.006","article-title":"Prevalence and outcomes of concomitant aortic stenosis and cardiac amyloidosis","volume":"77","author":"Nitsche","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2025.08.357_bib22","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1007\/s12350-023-03297-1","article-title":"Diagnostic accuracy of bone scintigraphy imaging for transthyretin cardiac amyloidosis: systematic review and meta-analysis","volume":"30","author":"Ahluwalia","year":"2023","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.cjca.2025.08.357_bib23","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1007\/s12350-022-03180-5","article-title":"Diagnostic value of heart-to-mediastinum ratio in 99mtc-pyrophospate SPECT\/CT for transthyretin cardiac amyloidosis","volume":"30","author":"Ikoma","year":"2023","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.cjca.2025.08.357_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2024.101809","article-title":"Deep learning approach for automated segmentation of myocardium using bone scintigraphy single-photon emission computed tomography\/computed tomography in patients with suspected cardiac amyloidosis","volume":"33","author":"Bhattaru","year":"2024","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.cjca.2025.08.357_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.nuclcard.2024.102019","article-title":"Quantitative (99m)tc-pyrophosphate myocardial uptake: changes on transthyretin stabilization therapy","volume":"39","author":"Vijayakumar","year":"2024","journal-title":"J Nucl Cardiol"},{"key":"10.1016\/j.cjca.2025.08.357_bib26","first-page":"244","article-title":"Diagnostic value of combined light and electron microscopic examination in endomyocardial biopsy in patients with cardiac amyloidosis","volume":"41","author":"Yamamoto","year":"2025","journal-title":"Can J Cardiol"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X25010530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X25010530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:32:17Z","timestamp":1777581137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X25010530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0828282X25010530"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2025.08.357","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and Initial Results from the Canadian Cardiac Amyloidosis Pyrophosphate Imaging Registry (CAPER)","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2025.08.357","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2025.08.344","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the Canadian Cardiovascular Society.","name":"copyright","label":"Copyright"}]}}